Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control

Infection with the human immunodeficiency virus (HIV), when left untreated, typically leads to disease progression towards acquired immunodeficiency syndrome. Some people living with HIV (PLWH) control their virus to levels below the limit of detection of standard viral load assays, without treatmen...

Full description

Bibliographic Details
Main Authors: Nicole F. Bernard, Sanket Kant, Zahra Kiani, Cécile Tremblay, Franck P. Dupuy
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.879124/full
_version_ 1811248468840153088
author Nicole F. Bernard
Nicole F. Bernard
Nicole F. Bernard
Nicole F. Bernard
Sanket Kant
Sanket Kant
Sanket Kant
Zahra Kiani
Zahra Kiani
Zahra Kiani
Cécile Tremblay
Cécile Tremblay
Franck P. Dupuy
Franck P. Dupuy
author_facet Nicole F. Bernard
Nicole F. Bernard
Nicole F. Bernard
Nicole F. Bernard
Sanket Kant
Sanket Kant
Sanket Kant
Zahra Kiani
Zahra Kiani
Zahra Kiani
Cécile Tremblay
Cécile Tremblay
Franck P. Dupuy
Franck P. Dupuy
author_sort Nicole F. Bernard
collection DOAJ
description Infection with the human immunodeficiency virus (HIV), when left untreated, typically leads to disease progression towards acquired immunodeficiency syndrome. Some people living with HIV (PLWH) control their virus to levels below the limit of detection of standard viral load assays, without treatment. As such, they represent examples of a functional HIV cure. These individuals, called Elite Controllers (ECs), are rare, making up <1% of PLWH. Genome wide association studies mapped genes in the major histocompatibility complex (MHC) class I region as important in HIV control. ECs have potent virus specific CD8+ T cell responses often restricted by protective MHC class I antigens. Natural Killer (NK) cells are innate immune cells whose activation state depends on the integration of activating and inhibitory signals arising from cell surface receptors interacting with their ligands on neighboring cells. Inhibitory NK cell receptors also use a subset of MHC class I antigens as ligands. This interaction educates NK cells, priming them to respond to HIV infected cell with reduced MHC class I antigen expression levels. NK cells can also be activated through the crosslinking of the activating NK cell receptor, CD16, which binds the fragment crystallizable portion of immunoglobulin G. This mode of activation confers NK cells with specificity to HIV infected cells when the antigen binding portion of CD16 bound immunoglobulin G recognizes HIV Envelope on infected cells. Here, we review the role of NK cells in antibody independent and antibody dependent HIV control.
first_indexed 2024-04-12T15:28:37Z
format Article
id doaj.art-e285ddd8d9c64b71beed535c31b0cf5b
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T15:28:37Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e285ddd8d9c64b71beed535c31b0cf5b2022-12-22T03:27:11ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-05-011310.3389/fimmu.2022.879124879124Natural Killer Cells in Antibody Independent and Antibody Dependent HIV ControlNicole F. Bernard0Nicole F. Bernard1Nicole F. Bernard2Nicole F. Bernard3Sanket Kant4Sanket Kant5Sanket Kant6Zahra Kiani7Zahra Kiani8Zahra Kiani9Cécile Tremblay10Cécile Tremblay11Franck P. Dupuy12Franck P. Dupuy13Research Institute of the McGill University Health Centre, Montreal, QC, CanadaDivision of Experimental Medicine, McGill University, Montreal, QC, CanadaInfectious Diseases, Immunology and Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaDivision of Clinical Immunology, McGill University Health Centre, Montreal, QC, CanadaResearch Institute of the McGill University Health Centre, Montreal, QC, CanadaDivision of Experimental Medicine, McGill University, Montreal, QC, CanadaInfectious Diseases, Immunology and Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaResearch Institute of the McGill University Health Centre, Montreal, QC, CanadaDivision of Experimental Medicine, McGill University, Montreal, QC, CanadaInfectious Diseases, Immunology and Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaCentre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, QC, CanadaDepartment of Microbiology Infectiology and Immunology, University of Montreal, Montreal, QC, CanadaResearch Institute of the McGill University Health Centre, Montreal, QC, CanadaInfectious Diseases, Immunology and Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaInfection with the human immunodeficiency virus (HIV), when left untreated, typically leads to disease progression towards acquired immunodeficiency syndrome. Some people living with HIV (PLWH) control their virus to levels below the limit of detection of standard viral load assays, without treatment. As such, they represent examples of a functional HIV cure. These individuals, called Elite Controllers (ECs), are rare, making up <1% of PLWH. Genome wide association studies mapped genes in the major histocompatibility complex (MHC) class I region as important in HIV control. ECs have potent virus specific CD8+ T cell responses often restricted by protective MHC class I antigens. Natural Killer (NK) cells are innate immune cells whose activation state depends on the integration of activating and inhibitory signals arising from cell surface receptors interacting with their ligands on neighboring cells. Inhibitory NK cell receptors also use a subset of MHC class I antigens as ligands. This interaction educates NK cells, priming them to respond to HIV infected cell with reduced MHC class I antigen expression levels. NK cells can also be activated through the crosslinking of the activating NK cell receptor, CD16, which binds the fragment crystallizable portion of immunoglobulin G. This mode of activation confers NK cells with specificity to HIV infected cells when the antigen binding portion of CD16 bound immunoglobulin G recognizes HIV Envelope on infected cells. Here, we review the role of NK cells in antibody independent and antibody dependent HIV control.https://www.frontiersin.org/articles/10.3389/fimmu.2022.879124/fullHIVelite controllersNK cellskiller immunoglobulin-like receptorsHLAADCC
spellingShingle Nicole F. Bernard
Nicole F. Bernard
Nicole F. Bernard
Nicole F. Bernard
Sanket Kant
Sanket Kant
Sanket Kant
Zahra Kiani
Zahra Kiani
Zahra Kiani
Cécile Tremblay
Cécile Tremblay
Franck P. Dupuy
Franck P. Dupuy
Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
Frontiers in Immunology
HIV
elite controllers
NK cells
killer immunoglobulin-like receptors
HLA
ADCC
title Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title_full Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title_fullStr Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title_full_unstemmed Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title_short Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title_sort natural killer cells in antibody independent and antibody dependent hiv control
topic HIV
elite controllers
NK cells
killer immunoglobulin-like receptors
HLA
ADCC
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.879124/full
work_keys_str_mv AT nicolefbernard naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT nicolefbernard naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT nicolefbernard naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT nicolefbernard naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT sanketkant naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT sanketkant naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT sanketkant naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT zahrakiani naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT zahrakiani naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT zahrakiani naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT ceciletremblay naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT ceciletremblay naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT franckpdupuy naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT franckpdupuy naturalkillercellsinantibodyindependentandantibodydependenthivcontrol